Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Significance of adrenomedullin...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Significance of adrenomedullin and the role of adrecizumab in sepsis

Significance of adrenomedullin and the role of adrecizumab in sepsis

Bibliographic Details
Main Author: Abhijit Nair
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Saudi Journal of Anaesthesia
Online Access:http://www.saudija.org/article.asp?issn=1658-354X;year=2021;volume=15;issue=2;spage=228;epage=229;aulast=Nair
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.saudija.org/article.asp?issn=1658-354X;year=2021;volume=15;issue=2;spage=228;epage=229;aulast=Nair

Similar Items

  • The mechanism of action of the adrenomedullin-binding antibody adrecizumab
    by: Christopher Geven, et al.
    Published: (2018-06-01)
  • Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats
    by: Alice Blet, et al.
    Published: (2019-05-01)
  • Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)
    by: Mahir Karakas, et al.
    Published: (2020-08-01)
  • Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial
    by: Dirk van Lier, et al.
    Published: (2022-12-01)
  • Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
    by: Christopher Geven, et al.
    Published: (2018-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs